SK13596A3 - 15,15-dialkyl-substituted derivatives of estradiol, preparation method of these compounds, intermediates of this method and a pharmaceutical composition - Google Patents

15,15-dialkyl-substituted derivatives of estradiol, preparation method of these compounds, intermediates of this method and a pharmaceutical composition Download PDF

Info

Publication number
SK13596A3
SK13596A3 SK135-96A SK13596A SK13596A3 SK 13596 A3 SK13596 A3 SK 13596A3 SK 13596 A SK13596 A SK 13596A SK 13596 A3 SK13596 A3 SK 13596A3
Authority
SK
Slovakia
Prior art keywords
compound
carbon atoms
group
dialkyl
alkyl group
Prior art date
Application number
SK135-96A
Other languages
English (en)
Slovak (sk)
Inventor
James R Bull
Karl-Heinrich Fritzemeier
Christa Hegele-Hartung
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of SK13596A3 publication Critical patent/SK13596A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SK135-96A 1993-08-02 1994-08-01 15,15-dialkyl-substituted derivatives of estradiol, preparation method of these compounds, intermediates of this method and a pharmaceutical composition SK13596A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4326240A DE4326240A1 (de) 1993-08-02 1993-08-02 15,15-Dialkyl-substituierte Derivate des Estradiols
PCT/EP1994/002540 WO1995004070A1 (en) 1993-08-02 1994-08-01 15,15-dialkyl-substituted derivatives of estradiol

Publications (1)

Publication Number Publication Date
SK13596A3 true SK13596A3 (en) 1997-03-05

Family

ID=6494482

Family Applications (1)

Application Number Title Priority Date Filing Date
SK135-96A SK13596A3 (en) 1993-08-02 1994-08-01 15,15-dialkyl-substituted derivatives of estradiol, preparation method of these compounds, intermediates of this method and a pharmaceutical composition

Country Status (21)

Country Link
US (2) US5587496A (de)
EP (1) EP0712412B1 (de)
JP (1) JPH09500891A (de)
KR (1) KR960703940A (de)
CN (1) CN1040329C (de)
AT (1) ATE175418T1 (de)
AU (1) AU674609B2 (de)
CA (1) CA2168657A1 (de)
CZ (1) CZ26796A3 (de)
DE (2) DE4326240A1 (de)
FI (1) FI960465A7 (de)
HU (1) HUT73238A (de)
IL (1) IL110530A (de)
MY (1) MY111121A (de)
NO (1) NO960425L (de)
NZ (1) NZ271091A (de)
PL (1) PL312792A1 (de)
RU (1) RU2147306C1 (de)
SK (1) SK13596A3 (de)
WO (1) WO1995004070A1 (de)
ZA (1) ZA945754B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4326240A1 (de) * 1993-08-02 1995-02-09 Schering Ag 15,15-Dialkyl-substituierte Derivate des Estradiols
DE4447401A1 (de) 1994-12-23 1996-07-04 Schering Ag 14,17-C¶2¶-überbrückte Steroide
DE19906159A1 (de) * 1999-02-09 2000-08-10 Schering Ag 16-Hydroxyestratriene als selektiv wirksame Estrogene
DE10151365A1 (de) * 2001-10-17 2003-04-30 Schering Ag 17-Chlor-D-Homosteroide als selektive Estrogenrezeptorantagonisten
MY142989A (en) * 2004-03-10 2011-02-14 Bayer Schering Pharma Ag Stabilised supersaturated solids of lipophilic drugs
DE602005014227D1 (de) * 2004-03-10 2009-06-10 Bayer Schering Pharma Ag Zusammensetzungen aus drospirenon in molekularer dispersion
US20050220825A1 (en) * 2004-03-10 2005-10-06 Adrian Funke Molecular dispersions of drospirenone

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2275752A (en) * 1938-11-25 1942-03-10 Ciba Pharm Prod Inc Cyclic condensation products and process of making same
US3472881A (en) * 1965-05-14 1969-10-14 Merck & Co Inc 3 - hydroxy - 13 - lower alkyl - 15 - carboxyl - 1,3,5(10),8,14 - gonapentaen - 17-ones and intermediates in the production thereof
US3766224A (en) * 1971-06-03 1973-10-16 Sandoz Ag 15-methyl-substituted steroids
DD145919B1 (de) * 1978-06-28 1982-06-30 Kurt Ponsold Verfahren zur herstellung von 14,1 -methylenderivaten der oestranreihe
DE3628189A1 (de) * 1986-08-20 1988-02-25 Schering Ag Oestrogen wirksame mittel und 14,17ss-ethano-14ss-estratriene
DE4326240A1 (de) * 1993-08-02 1995-02-09 Schering Ag 15,15-Dialkyl-substituierte Derivate des Estradiols

Also Published As

Publication number Publication date
NO960425D0 (no) 1996-02-01
DE69415812D1 (de) 1999-03-18
EP0712412B1 (de) 1999-01-07
KR960703940A (ko) 1996-08-31
CN1040329C (zh) 1998-10-21
NO960425L (no) 1996-04-02
HU9600234D0 (en) 1996-04-29
PL312792A1 (en) 1996-05-13
HUT73238A (en) 1996-07-29
CZ26796A3 (en) 1996-07-17
CN1128031A (zh) 1996-07-31
ATE175418T1 (de) 1999-01-15
MY111121A (en) 1999-08-30
FI960465A0 (fi) 1996-02-01
EP0712412A1 (de) 1996-05-22
AU7461094A (en) 1995-02-28
FI960465L (fi) 1996-02-01
CA2168657A1 (en) 1995-02-09
WO1995004070A1 (en) 1995-02-09
JPH09500891A (ja) 1997-01-28
IL110530A (en) 1998-08-16
FI960465A7 (fi) 1996-02-01
AU674609B2 (en) 1997-01-02
RU2147306C1 (ru) 2000-04-10
US5656622A (en) 1997-08-12
ZA945754B (en) 1995-03-15
NZ271091A (en) 1996-08-27
DE69415812T2 (de) 1999-09-16
US5587496A (en) 1996-12-24
DE4326240A1 (de) 1995-02-09
IL110530A0 (en) 1994-11-11

Similar Documents

Publication Publication Date Title
US20040029847A1 (en) 8Beta-substituted-11-beta-pentyl-and 11-beta-hexyl-estra-1,3,5(10)-triene derivatives
JPS61194096A (ja) １１β‐アリール‐エストラジエン、その製法及びこれを含有する抗ゲスターゲン及び抗糖質コルチコイド製剤
JP2003505394A (ja) 経口活性アンドロゲン
US20040198711A1 (en) 15Alpha-substituted estradiol carboxylic acid esters as locally active estrogens
EP0712412B1 (de) 15,15-dialkylsubstituierte östradiolderivate
US6677329B1 (en) Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11
JPH0515720B2 (de)
EP1212345B1 (de) Oral wirksame 7-alpha-alkyl androgene
FI102902B (fi) Menetelmä terapeuttisesti käyttökelpoisten 14 ,17 -silloitettujen es tratrieenien valmistamiseksi
US20040059140A1 (en) 14(15)-unsaturated 15- and/or 16-substituted androgens with mixed androgen-progrestational profile
US5418227A (en) 14,16β-ethano-15β, 16(1)-cyclo-14β-estra-1,3,5(10)-trienes
JP4279552B2 (ja) 新規アンドロゲンとしてのメチレンステロイド
US5439902A (en) 14α, 16α-ethanoand 14α, 16α-etheno-estratrienes